EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION

Show other versions (1)

Aim. To study the efficacy of rosuvastatin in dyslipidemia correction in patients after Q-wave myocardial infarction (Q-MI).Material and methods. 40 patients (aged 52.7±9.4 years old) were included into the study after 10-14 days of the acute Q-MI onset. Determination of blood lipids profile, alanin...

Full description

Bibliographic Details
Published in:Рациональная фармакотерапия в кардиологии
Main Authors: R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
Format: Article
Language:English
Published: Столичная издательская компания 2015-09-01
Subjects:
myocardial infarction
lipids
low-density lipoprotein cholesterol
liver transaminase
Online Access:https://www.rpcardio.online/jour/article/view/212

Internet

https://www.rpcardio.online/jour/article/view/212

Similar Items